Advanced endometriosis. Endometriosis
Conditions
Interventions
Intervention 1: Intervention group: The first group will receive the dienogest drug. Dosage of one tablet of 2 mg daily for six months. Intervention 2: Intervention group: The second group will receiv
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Early diagnosis of endometriosis and chronic pelvic pain associated with endometriosis Patients with advanced endometriosis who underwent surgery Age 18 - 45 years Body mass index (BMI) 18.5 – 29.9 kg/m2; No gynecological malignancy No contraindications to OCP or dienogest No plans of pregnancy in the near No underlying diseases
Exclusion criteria
Exclusion criteria: Personal dissatisfaction for inclusion in the study Patients whose pelvic pain originates from other organs Use of gonadotropins or other hormones three months before surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before surgery, 3 and 6 months after surgery. Method of measurement: Pelvic pain and dyspareunia scores are evaluated using the Visual Analogue Scale (VAS) and dysuria and dyschezia using a three-point score questionnire by possible answers to the items were “yes”, “no”, and “a little”. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: Before surgery, 3 and 6 months after surgery. Method of measurement: Quality of life was measured using WHOQOL-BREF.;Edverse effects of the treatment. Timepoint: 3 and 6 months after surgery. Method of measurement: Questionnaire.;Pain recurrence. Timepoint: 6 months after surgery. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGelareh Niakan
Iran University of Medical Sciences
Outcome results
None listed